Keyword: Nabriva Therapeutics
The positive readout further burnishes the prospects of the antibiotic, which is set to go before the FDA later this year.
Roivant Sciences is adding a late-phase drug to its pipeline: Nabriva's pneumonia antibiotic lefamulin.
Dominic Caruso retires as J&J's CFO, CVS hires ex-Lilly CFO Rice as the president of its PBM unit, former FDA informatics chief Kass-Hout joins Amazon.
Lefamulin held its own against established treatment moxifloxacin, raising hopes that Nabriva can establish it as a first-line treatment of CABP.
California investment firm Vivo Capital, known for its big pharma and med dev raises, has closed a new healthcare venture capital fund at over $100 million that will include funds being funneled into biotech startups.
Nabriva Therapeutics has initiated the second of two pivotal Phase III trials of its antibiotic lefamulin.